Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Enterprise Value: 2019-2025

Historic Enterprise Value for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to $5.7 billion.

  • Legend Biotech's Enterprise Value fell 41.74% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 billion, marking a year-over-year decrease of 47.59%. This contributed to the annual value of $5.7 billion for FY2024, which is 41.17% down from last year.
  • Per Legend Biotech's latest filing, its Enterprise Value stood at $5.7 billion for Q3 2025, which was down 8.37% from $6.3 billion recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Enterprise Value peaked at $11.2 billion during Q3 2023, and registered a low of $4.6 billion during Q2 2021.
  • For the 3-year period, Legend Biotech's Enterprise Value averaged around $8.2 billion, with its median value being $9.3 billion (2024).
  • Per our database at Business Quant, Legend Biotech's Enterprise Value soared by 2,910.37% in 2021 and then crashed by 41.74% in 2025.
  • Over the past 5 years, Legend Biotech's Enterprise Value (Quarterly) stood at $6.1 billion in 2021, then rose by 10.66% to $6.7 billion in 2022, then surged by 43.46% to $9.7 billion in 2023, then tumbled by 41.17% to $5.7 billion in 2024, then tumbled by 41.74% to $5.7 billion in 2025.
  • Its last three reported values are $5.7 billion in Q3 2025, $6.3 billion for Q2 2025, and $5.8 billion during Q1 2025.